Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H22FN3O |
| Molecular Weight | 327.3959 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(=O)CCCN2CCN(CC2)C3=CC=CC=N3
InChI
InChIKey=XTKDAFGWCDAMPY-UHFFFAOYSA-N
InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2
| Molecular Formula | C19H22FN3O |
| Molecular Weight | 327.3959 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.elephantcare.org/Drugs/azaperon.htm
Sources: http://www.elephantcare.org/Drugs/azaperon.htm
Azaperone (Stresnil, Fluoperidol) is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects. It is mainly as a tranquilizer in veterinary medicine. Azaperone is officially indicated for the “control of aggressiveness when mixing or regrouping weanling or feeder pigs weighing up to 36.4 kg”. It is also used clinically as a general tranquilizer for swine, in particular with aggressive sows to allow piglets to be accepted, and as a preoperative agent prior to general anesthesia or cesarian section with local anesthesia. Azaperone has also been used as a neuroleptic in horses, but some horses develop adverse reactions (sweating, muscle tremors, panic reaction, CNS excitement) and IV administration has resulted in significant arterial hypotension in the horse; because of these effects, most clinicians avoid the use of this drug in equines. Azaperone appears to have minimal effects on respiration and may inhibit some of the respiratory depressant actions of general anesthetics. A slight reduction of arterial blood pressure has been measured in pigs after IM injections of azaperone, which is apparently due to slight alpha-adrenergic blockade. Azaperone has been demonstrated to prevent the development of halothane-induced malignant hyperthermia in susceptible pigs. Preliminary studies have suggested that the effects of butyrephenones may be antagonized by 4-aminopyridine. Azaperone acts primarily as a dopamine antagonist but also has some antihistaminic and anticholinergic properties as seen with similar drugs such as haloperidol. Azaperone may cause hypotension and while it has minimal effects on respiration in pigs, high doses in humans can cause respiratory depression which may be why it is rarely used in humans. Higher doses are used for anesthesia in combination with other drugs such as xylazine, tiletamine and zolazepam. Azaperone is also used in combination with strong narcotics such as etorphine or carfentanil for tranquilizing large animals such as elephants.
CNS Activity
Sources: http://www.redalyc.org/html/919/91931189013/
Curator's Comment: Azaperone is thought to act on CNS to make animals indifferent to their surrounding environment
Originator
Sources: http://www.google.co.ve/patents/CA2732940A1
Curator's Comment: # Janssen Pharmaceutica laboratories
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model. | 2010-11 |
|
| 64-channel multi-detector row CT angiographic evaluation of the micropigs for potential living donor lung transplantation. | 2010-09 |
|
| Increasing abdominal pressure with and without PEEP: effects on intra-peritoneal, intra-organ and intra-vascular pressures. | 2010-07-04 |
|
| Haloperidol and azaperone in drive-net captured Southern chamois (Rupicapra pyrenaica). | 2010-07 |
|
| Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. | 2010-07 |
|
| Preclinical electrogastrography in experimental pigs. | 2010-06 |
|
| Use of haloperidol and azaperone for stress control in roe deer (Capreolus capreolus) captured by means of drive-nets. | 2010-06 |
|
| Low plasma potassium in deep hypothermic cardiac arrest indicates that cardiac arrest is secondary to hypothermia: a porcine study. | 2010-06 |
|
| Minimum alveolar concentrations and hemodynamic effects of two different preparations of sevoflurane in pigs. | 2010-05 |
|
| Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs. | 2010-04-06 |
|
| Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model. | 2010-04 |
|
| Multidetector row computed tomography evaluation of the micropig kidney as a potential renal donor. | 2010-03 |
|
| Wireless video capsule enteroscopy in preclinical studies: methodical design of its applicability in experimental pigs. | 2010-03 |
|
| Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model. | 2010-01-04 |
|
| The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance. | 2010-01 |
|
| Acid-base balance and ventilation during sternal and lateral recumbency in field immobilized black rhinoceros (Diceros bicornis) receiving oxygen insufflation: a preliminary report. | 2010-01 |
|
| Psychological interventions in the management of common skin conditions. | 2010 |
|
| Anti- or profibrillatory effects of Na(+) channel blockade depend on the site of application relative to gradients in repolarization. | 2010 |
|
| Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems. | 2010 |
|
| Postmortem Evaluation of Left Flank Laparoscopic Access in an Adult Female Giraffe (Giraffa camelopardalis). | 2010 |
|
| Resource efficiency and economic implications of alternatives to surgical castration without anaesthesia. | 2009-11 |
|
| Different solutions used for submucosal injection influenced early healing of gastric endoscopic mucosal resection in a preclinical study in experimental pigs. | 2009-09 |
|
| Computer tomographic investigation of subcutaneous adipose tissue as an indicator of body composition. | 2009-07-01 |
|
| Rapid method for the determination of tranquilizers and a beta-blocker in porcine and bovine kidney by liquid chromatography with tandem mass spectrometry. | 2009-04-01 |
|
| Butorphanol, azaperone, and medetomidine anesthesia in free-ranging white-tailed deer (Odocoileus virginianus) using radiotransmitter darts. | 2009-04 |
|
| Butorphanol-azaperone-medetomidine for immobilization of captive white-tailed deer. | 2009-04 |
|
| Comparison of azaperone-detomidine-butorphanol-ketamine and azaperone-tiletamine-zolazepam for anaesthesia in piglets. | 2009-03 |
|
| Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. | 2009-03 |
|
| Simultaneous determination of azaperone and azaperol in animal tissues by HPLC with confirmation by electrospray ionization mass spectrometry. | 2009-01-15 |
|
| [Determination of azaperone and carazolol residues in animals kidney using LC-MS/MS method]. | 2009 |
|
| Thermal, cardiorespiratory and cortisol responses of impala (Aepyceros melampus) to chemical immobilisation with 4 different drug combinations. | 2008-09 |
|
| Evaluation of intramuscular butorphanol, azaperone, and medetomidine and nasal oxygen insufflation for the chemical immobilization of white-tailed deer, Odocoileus virginianus. | 2008-09 |
|
| Does carbon monoxide treatment alter cytokine levels after endotoxin infusion in pigs? A randomized controlled study. | 2008-08-07 |
|
| Immobilization of black bears (Ursus americanus) with a combination of butorphanol, azaperone, and medetomidine. | 2008-07 |
|
| A novel method for transuterine identification of piglets. | 2008-07 |
|
| Comprehensive screening and quantification of veterinary drugs in milk using UPLC-ToF-MS. | 2008-07 |
|
| Comparison of cardiac function and coronary angiography between conventional pigs and micropigs as measured by multidetector row computed tomography. | 2008-06 |
|
| Bioavailability of heme iron in biscuit filling using piglets as an animal model for humans. | 2008-02-18 |
|
| Reliability of continuous cardiac output measurement during intra-abdominal hypertension relies on repeated calibrations: an experimental animal study. | 2008 |
|
| Alveolar recruitment can be predicted from airway pressure-lung volume loops: an experimental study in a porcine acute lung injury model. | 2008 |
|
| Successful treatment of a squamous cell carcinoma in a white rhinoceros, Ceratotherium simum. | 2007-12 |
|
| Changes in the relative thickness of individual subcutaneous adipose tissue layers in growing pigs. | 2007-11-07 |
|
| The cardiopulmonary effects of etorphine, azaperone, detomidine, and butorphanol in field-anesthetized white rhinoceroses (Ceratotherium simum). | 2007-09 |
|
| Anaesthesia for castration of piglets: comparison between intranasal and intramuscular application of ketamine, climazolam and azaperone. | 2007-09 |
|
| Determination of residues of azaperone in the kidneys by liquid chromatography with fluorescence detection. | 2007-03-14 |
|
| Mild hypothermia reduces cardiac post-ischemic reactive hyperemia. | 2007-02-26 |
|
| The litterbox blues. | 2007-01 |
|
| Vasopressin improves survival in a porcine model of abdominal vascular injury. | 2007 |
|
| Use of buspirone and enrichment to manage aberrant behavior in an American badger (Taxidea taxus). | 2005-09 |
|
| Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs. | 2004-12 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.elephantcare.org/Drugs/azaperon.htm
Swine: a) For approved indication of mixing feeder or weanling pigs: 2.2 mg/kg deeply IM' b) Preanesthetic: 2 - 4 mg/kg IM; Immobilizing agent: 5.3 - 8 mg/kg IM; c) Sedation: 1 mg/kg IM; Reduction of aggressiveness: 2.5 mg/kg IM;
Total dose of azaperone for adult Asian captive elephants 80-100 mg; up to 140 mg for a large elephant. Induction in 20-30 minutes; duration 45-60 minutes Knock-down or immobilant: 5 - 10 mg/kg IM
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:52:40 GMT 2025
by
admin
on
Wed Apr 02 06:52:40 GMT 2025
|
| Record UNII |
19BV78AK7W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
||
|
WHO-VATC |
QN01AX91
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
||
|
WHO-VATC |
QN05AD90
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
||
|
CFR |
21 CFR 522.150
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2331
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
1649-18-9
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
DB11376
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
19BV78AK7W
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
2601502
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
88301
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
D001376
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
m2161
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
19BV78AK7W
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
SUB05636MIG
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
1045756
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
170976
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
15443
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
Azaperone
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
216-715-8
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
C74187
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
DTXSID2045361
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
100000086911
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL340211
Created by
admin on Wed Apr 02 06:52:40 GMT 2025 , Edited by admin on Wed Apr 02 06:52:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |